Key statistics
On Thursday, Karolinska Development AB (KDEV:STO) closed at 1.29, 9.88% above its 52-week low of 1.17, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.24 |
---|---|
High | 1.29 |
Low | 1.24 |
Bid | -- |
Offer | -- |
Previous close | 1.26 |
Average volume | 223.15k |
---|---|
Shares outstanding | 267.52m |
Free float | 95.37m |
P/E (TTM) | -- |
Market cap | 337.08m SEK |
EPS (TTM) | -0.0209 SEK |
Data delayed at least 15 minutes, as of Sep 19 2024 17:00 BST.
More ▼
- Karolinska Developments portföljbolag AnaCardio rapporterar framsteg i två kliniska studier av läkemedelskandidaten AC01
- Karolinska Development’s portfolio company AnaCardio reports progress in two clinical trials with its drug candidate AC01
- Karolinska Developments portföljbolag BOOST Pharma presenterar positiva top line-resultat från en fas 1/2-studie med över 75% minskning av frakturfrekvensen hos barn med sällsynt bensjukdom
- Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease
- Karolinska Developments portföljbolag Biosergen meddelar framgångsrik behandling av första patienten i klinisk studie med BSG005
- Karolinska Development’s portfolio company Biosergen announces successful treatment of first patient in a clinical trial of BSG005
- Interim Report - January-June 2024
- Delårsrapport för januari – juni 2024
- Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator
- Karolinska Developments portföljbolag PharmNovo erhåller EUR 17,5 miljoner i finansiering från innovationsprogrammet EIC Accelerator
More ▼